AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. SATO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Accounts receivable, net

SATO PHARMACEUTICAL CO.,LTD.【JP:E00954】

Market cap
P/E ratio
SummaryFinancialsDividendsHistorySegmentsWorkforce
Period EndAccounts receivable, net (Million JPY)YoY (%)
Jul 31, 202317,288+0.46%
Jul 31, 202217,208+5.42%
Jul 31, 202116,324+13.72%
Jul 31, 202014,355-7.61%
Jul 31, 201915,538+15.46%
Jul 31, 201813,457+8.89%
Jul 31, 201712,358-9.58%
Jul 31, 201613,668+12.37%
Jul 31, 201512,163-1.04%
Jul 31, 201412,291

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)